Last Price Today's Change   Day's Range   Trading Volume
5.88   -0.01 (0.17%)  5.83 - 5.92  3,567,600
Trade this stock for as low as 0.05% brokerage. Find out more.


Market Cap: 19,871 Million
NOSH: 3,379 Million
Avg Volume (4 weeks):8,707,915
4 Weeks Range:5.67 - 6.44
4 Weeks Price Volatility (%):
52 Weeks Range:4.52 - 6.44
52 Weeks Price Volatility (%):
Average Price Target: 5.73
Price Target Upside/Downside: -0.15

Financial Highlight

Latest Quarter | Ann. Date 31-Dec-2019 [#3]  |  11-Feb-2020
Next QR | Est. Ann. Date: 31-Mar-2020  |  07-May-2020
T4Q P/E | EY: 48.40  |  2.07%
T4Q DY | Payout %: 1.25%  |  60.36%
T4Q NAPS | P/NAPS: 0.7267  |  8.09
T4Q NP Margin | ROE: 14.54%  |  16.72%


Date Subject
20-Feb-2020 下跌股:贺特佳RM5.73支撑
13-Feb-2020 [转贴] [HARTALEGA HOLDINGS BHD:第六工厂的第一条生产线已于2020年1月投入使用,其余生产线将逐步投产,以满足不断增长的需求;一旦建成,第六工厂的年产量将达到47亿个] - James的股票投资James Share Investing
12-Feb-2020 【行家论股/视频】贺特佳 估值昂贵宜减码
12-Feb-2020 [转贴] [Facebook live video:浅谈Hartalega holdings bhd (Harta)] - James的股票投资James Share Investing
12-Feb-2020 Hartalega Holdings Berhad - Within Expectations
12-Feb-2020 Hartalega - Riding Steady on Increasing Global Demand
12-Feb-2020 Hartalega - Better Outlook Ahead
12-Feb-2020 Hartalega Holdings Bhd - Higher Demand Amid Global Health Crisis
12-Feb-2020 [转贴] HARTA Q3 简单分析 - 蛤蜊先生
12-Feb-2020 Hartalega Holdings Berhad - Momentum Remains
12-Feb-2020 Hartalega Holdings - 3rd Consecutive Sequential Earnings Improvement, Gathering Momentum
12-Feb-2020 Hartalega - Higher Sales Volume Generated in 3QFY20
12-Feb-2020 Hartalega Holdings - Higher sales volume but flattish ASP QoQ
11-Feb-2020 Trading Stocks - Hartalega
07-Feb-2020 Rubber Gloves - Demand Surge To Amplify Earnings
06-Feb-2020 World’s biggest glove-maker rallies with deadly virus spreading
04-Feb-2020 Positive on Malaysia Rubber Glove Sector: TOPG and HART
29-Jan-2020 Rubber Gloves – Malaysia - New Coronavirus Sparks Loftier But Justified Valuations
22-Jan-2020 Malaysia Gloves Sector - High Possibility of Pandemic Outbreak
22-Jan-2020 Hartalega Holdings - Higher Demand to Boost Earnings

Business Background

Hartalega Holdings is a holding company whose subsidiaries manufacture and sell a variety of nitrile and latex gloves. The company's gloves are used in laboratories and healthcare facilities. The gloves are also sold to manufacturers of semiconductors and consumer electronics and for automotive maintenance and spray painting. The company organizes itself into six segments based on geography: North America, Europe, Asia, Australia, Malaysia, and South America. More revenue comes from the North America segment than any other.
Analyze this stock with MQ Trader system

  7 people like this.
itstime Anyone realise usually Harta every QR mentioned about they working on FDA approval. Suddenly this QR not mention anything about FDA...
11/02/2020 8:29 PM
stock_hunt got liao mai no need update lo...lol..wait to announce...hehe
11/02/2020 9:20 PM
gemfinder No surprise.. sell
11/02/2020 9:30 PM
kk7198 Just keep and not need to sell,just spend your quarterly dividend.
11/02/2020 9:51 PM
stanic88 As long as stays at rm6.00 until next quarter with 30% yoy improve, or 40% yoy growth consider good d.
12/02/2020 12:29 AM
Mabel Well done Malaysia.

18 millions contribution from the industry is very commendable..

Very proud to be associated with this company!

Happy to be on board together with her sister Top Gloves..

12/02/2020 12:42 AM
mileskoon If you guys are looking for virus theme play, take a look at biohldg, it is one of the pharmacy and health supplement counter. The demand of vitamin and health supplement is increasing recently. Surprisingly, the share price is still trading at bottom, means the downside risk is limited, while upside risk is huge. It would rebound back it's fair value in near future. The beast is yet to wake up.
12/02/2020 7:09 AM
kk7198 @mileskoon, Harta is for long term as their management is cleaner...not like Topglove with Aspion saga and is far sighted like AMG which is getting approval from FDA in this year.Now is not virus theme play as the virus is peaking this month.
12/02/2020 7:25 AM
gemfinder New virus cases drop sgsin.. peak soon. Sell gloves
12/02/2020 7:28 AM
kk7198 Sell but make sure to collect back.
12/02/2020 8:13 AM
ov123 This is easily one of the best listed glove companies in Bursa.
12/02/2020 9:59 AM
learner35 1st timer buy share, should i buy some now or wait?
12/02/2020 10:34 AM
T1T4N Its not about the virus cases drop or what.

Olympic 2020 is at JAPAN, the most affected country outside china.
Coming Euro2020 also (football)

Do you think the demand will DROP due to virus case turn better?

Think again.
12/02/2020 1:06 PM
Mabel Just buy and forget..
12/02/2020 2:13 PM
Chelsea Global glove demand surge where Malaysia order increase from 192B to 230B (additional 38B) which equivalent to half Top glove. This demand will continue grow due health concern awareness which arise from flu virus in US and COVID-19. As u can c, past 5 years the CAGR average is 12% compare with 7% on past decade. My target for Harta after include plant 6 is rm7 and plant 7 is rm7.8

12/02/2020 2:17 PM
gggSTOCK TP 7 by end of the month
12/02/2020 3:14 PM
kenie New coronavirus vaccine may be faster to develop
KUALA LUMPUR (Feb 12): With the number of cases and deaths already surpassing that of SARS, teams around the world are racing to come up with a vaccine against the novel coronavirus (Covid-19).
At the time of writing, the virus has infected 45,194 people and killed 1,114 others.
Developing a vaccine safe for human use typically takes years, but there is reason to believe that the process will be speedier this time around, said academician and virologist Emeritus Prof Datuk Dr Lam Sai Kit.
“Advances in technology now makes it possible to come up with candidate vaccines in a matter of weeks, unlike traditional methods which can take years,” he told Bernama when contacted.
In addition to that, scientists in China sequenced the virus’s genome and made it available on Jan 10, just a month after the Dec 8 report of the first case of pneumonia from an unknown virus in Wuhan.
In contrast, scientists took more than half a year to sequence the SARS coronavirus after the outbreak began in late 2002.

How long will it take?
Lam noted that although candidate vaccines may be available in a matter of weeks, it would take much longer for them to be evaluated for human use.
“These candidate vaccines have to be tested in animal studies before human clinical trials can be started. It is still a long road ahead, and by the time a vaccine is ready, the outbreak may already be over — like in the case of SARS, where it took 20 months before a candidate vaccine was developed,” said Lam.
The vaccine never made it to the market because the virus was successfully contained with public health measures. The vaccine against MERS, meanwhile, is still being developed.
Immunologist Datuk Dr Musa Nordin said despite the pressure to come up with a vaccine as soon as possible, it must be noted that vaccine development remains an expensive and risky process.
“On average, it takes 10 years from pre-clinical trials through Phase 1-3 clinical trials before it is proven efficacious and safe for registration by regulatory bodies and use in man.
“However, the Covid-19 has the benefit of experience with previous candidate vaccines for MERS and SARS, allowing a jump start on the development of vaccines. If I had to hazard a best optimistic guess, I would say (a Covid-19 vaccine would be developed) within six months,” he said to Bernama.

What if it mutates?
One of the fears is that the Covid-19 would mutate after a vaccine is finally developed, affecting its efficacy.
However, it should be noted that Covid-19 does not undergo the same type of genome shuffling as the influenza virus, which is constantly mutating.
Like SARS, the genome of the Covid-19 comprises a single strand of RNA (ribonucleic acid). Microbes with such genome are known to mutate very quickly, but SARS has a molecular proofreading system that reduces its mutation rate.
Given the similarity to SARS at the genomic level, it has been suggested that the Covid-19 would not be as prone to mutation as the flu virus, which comprises multiple single-stranded RNA segments.
Therefore, if a vaccine is produced, it would still be effective.
Lam said that mutation is always a possibility with RNA viruses like the Covid-19.
“Usually, a major change happens when the virus jumps species. Hopefully, if there is a mutation, it will be a minor and not involving the spike protein, which is the important antigen used to produce the neutralising antibody in our immune system.
“With minor changes, the vaccine will still offer protection, or modify the severity of the disease,” he said.
The Coalition of Endemic Preparedness Innovations (CEPI) in January announced that it would be funding three programmes to develop vaccines against the 2019-nCov.
It has engaged, among others, the Queensland University to work on a vaccine using its recently developed rapid response technology.
The university’s head of School of Chemistry and Molecular Biosciences Prof Paul Young said that they would be using the novel technology, known as the molecular clamp, for the rapid generation of the vaccine.
Young’s team of researchers have already experienced using this novel technology to produce candidate vaccines against influenza, Nipah, Ebola, and MERS. The team is optimistic that it will be able to develop the Covid-19 vaccine within six months.
“We are working around the clock to produce enough of the spike proteins in cells to produce this sub-unit vaccine,” said Young in an email.
A sub-unit vaccine is a fragment of a pathogen, typically a surface protein that is used to trigger an immune response. This in turn will stimulate acquired immunity against the pathogen from which it is derived.
CEPI is a non-profit organisation formed in 2017 to fund vaccine development for emerging infectious diseases. It is based in Oslo, Norway, and is a global partnership created to spearhead development
12/02/2020 3:34 PM
Alibaba Limskeong what happens to harta C28, mother up son go down, anyone know this.....?
12/02/2020 5:50 PM
James Ng https://klse.i3investor.com/blogs/general/2020-02-12-story-h1483791340.jsp
[转贴] [Facebook live video:浅谈Hartalega holdings bhd (Harta)] - James的股票投资James Share Investing
12/02/2020 9:28 PM
ching9 what happens to harta C28, mother up son go down, anyone know this.....? + 1
12/02/2020 5:50 PM

Same enquiry , Anyone possible reason to share?
12/02/2020 11:50 PM
gemfinder Virus peak liao. Sell gloves
13/02/2020 7:27 AM
James Ng https://klse.i3investor.com/blogs/general/2020-02-13-story-h1483791490.jsp
[转贴] [HARTALEGA HOLDINGS BHD:第六工厂的第一条生产线已于2020年1月投入使用,其余生产线将逐步投产,以满足不断增长的需求;一旦建成,第六工厂的年产量将达到47亿个] - James的股票投资James Share Investing
13/02/2020 7:53 AM
skybursa More than 14,000 new case & death over 280
13/02/2020 8:21 AM
skybursa 242 reported death
13/02/2020 8:24 AM
cheeseburger looking at spiking up confirmed case hit 60k, is very unlikely the demand for gloves not follow suit. It will only go up not come down. The stock analysis really need do homework before you call it too expensive. It is reasonable with much higher demand flooding the counter.
13/02/2020 9:04 AM
chl1989 it will go back to rm7 very soon
13/02/2020 12:21 PM
Jerichomy Pls dont accumulate now, my friend in adventa and ocncash told me that banker oredi left all the mask and glove counter...they are in steel counters...pls feel free to join them
13/02/2020 9:48 PM
JunJun left? it has barely begun
13/02/2020 9:56 PM
meistsk3134 rm7 next year
13/02/2020 10:30 PM
Chelsea lol Jerichomy don't listen to others. Please refer to the top 20 fund as closing 31 January 2020 where mostly new fund enter except Supermax.
14/02/2020 2:20 PM
gggSTOCK dont listen to those stupid analyst, they got paid even if they write rubbish
14/02/2020 5:06 PM
Rf888 Dont simply listen of analyst, please go do your own homework. Now china urgent need glove, next quarter result is very important. Please go study the result, you will get hint inside.

In line with growing rubber glove demand globally, Hartalega will continue with its NGC
capacity expansion plans. First line of Plant 6 was commissioned in January 2020 with
remaining production lines to come on stream progressively to cater for the rising demand.
Plant 6 will have an annual installed capacity of 4.7 billion pieces once completed. Plant 7 is
also in the expansion pipeline catering to small orders, focusing more on specialty products
and will have an annual installed capacity of 3.4 billion pieces. With the progressive
commissioning of Plant 6 and 7, Hartalega’s annual installed capacity is expected to increase
from the current 36.6 billion to 44.7 billion pieces by FY2022.
15/02/2020 1:50 PM
Rf888 The virus will effect many industries, only glove counter is super safe now and the fundamental is super good compare with others industry. This is the time, see back the H1N1 time how the glove counter result? Dont simply sell out your glove counter, is time to win big.
15/02/2020 1:53 PM
Rf888 When ppl scare, you need brave.
15/02/2020 1:54 PM
probability no of new confirmed infections per day had been clearly dropping....:

5th Feb: 3927
6th Feb: 3723
7th Feb: 3163
8th Feb: 3437
9th Feb: 2676
10th Feb: 3001
11th Feb: 2546
12th Feb: 1970
13th Feb: 1819
14th Feb: 1995
15th Feb: 1500


90% of the above cases was in Hubei only, meaning only about 200 confirmed cases in China outside Hubei.

I think the war on the virus internationally is over.

what more today OUTSIDE China:

ONLY 1 CASE reported!
15/02/2020 1:55 PM
Rf888 You can imagine how big 14 billion people china market?
15/02/2020 2:04 PM
probability may be can market in hubei only now...outside hubeis is only 200 confirmed cases per day...

even hubei will be completely under control in a month
15/02/2020 2:04 PM
Rf888 The real amount and you get the report amount at internet is big different, of course also hope this virus can get vaccine early.
15/02/2020 2:37 PM
gggSTOCK break 6.20 today then it will fly
17/02/2020 9:36 AM
hotmission fly down south...
19/02/2020 10:03 AM
chl1989 rm7 buy
19/02/2020 10:06 AM
sathishfiles 5.9 going down ??
19/02/2020 11:03 AM
yoyo Glove counters heat should b over concurrently with the dropping rate of virus infected cases. Harta TP RM5.20
19/02/2020 12:16 PM
WanUtama2015 Rf888, the China population is 1.4 billion ( 14亿 or 1400 million ), not 14 billion.
19/02/2020 3:32 PM
Gtrade yesterday new Covid-19 cases drop to 359. good sign but with 1400m China workforce and masses back to work, or released from quarantine, any sparks new clusters would swing the authority in panic mode again. This time it may even be too widespread to manage.For the next 6 monhs, heightened demand for gloves ,and hygien equipment will continue
20/02/2020 12:59 PM
ttluck no need worry la.....glove stock quite stable altough virus gone with the wind...hehe....looking longer term
20/02/2020 5:41 PM
presswood True, nx QR sure big green, epf will buy back after dividen, everywhere using glove, why worried
20/02/2020 7:49 PM
T1T4N This is a Glove Stock.
Not a Anti CoronaVirus stock.

Health Conscious UP = Glove Stock UP.
USD UP = Export Earnings UP (Glove)
21/02/2020 1:06 PM
RiskToRich 100% agreed with T1T4N....The whole world had learned another round of lesson from recent Coronavirus , everyone everywhere every country getting more hygienic... Demand for sure will sudden surge with new mkt , existing glove users like doctor nurses will increase the frequency to change their hand glove ....
23/02/2020 9:17 AM
icon123 Pharmaniaga experiencing a surge in demand for PPE like glove, mask as well flu vaccine/ medicine.

23/02/2020 10:35 AM


420  316  517  739 

Top 10 Active Counters
 EDUSPEC 0.03+0.005 
 XOX 0.050.00 
 PWORTH 0.02-0.005 
 XDL 0.17+0.01 
 PWRWELL 0.3750.00 
 PERDANA 0.47-0.01 
 ISTONE 0.24+0.015 
 MTOUCHE 0.175-0.015 
 INNATURE 0.59-0.065 
 HSI-H8T 0.48+0.045 
Partners & Brokers